• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

DNA damage response genes as biomarkers of therapeutic outcomes in acute myeloid leukemia patients.

作者信息

Karami Adam, Skorski Tomasz

机构信息

Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA.

Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA.

出版信息

Leukemia. 2024 Jun;38(6):1407-1410. doi: 10.1038/s41375-024-02269-9. Epub 2024 May 11.

DOI:10.1038/s41375-024-02269-9
PMID:38734788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11147752/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ee/11147752/19ab95df0af9/41375_2024_2269_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ee/11147752/7beeb94cd573/41375_2024_2269_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ee/11147752/19ab95df0af9/41375_2024_2269_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ee/11147752/7beeb94cd573/41375_2024_2269_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4ee/11147752/19ab95df0af9/41375_2024_2269_Fig2_HTML.jpg

相似文献

1
DNA damage response genes as biomarkers of therapeutic outcomes in acute myeloid leukemia patients.DNA损伤反应基因作为急性髓系白血病患者治疗结果的生物标志物
Leukemia. 2024 Jun;38(6):1407-1410. doi: 10.1038/s41375-024-02269-9. Epub 2024 May 11.
2
Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.急性髓系白血病中全面的 DNA 修复基因表达分析及其预后意义。
Hematology. 2021 Dec;26(1):904-913. doi: 10.1080/16078454.2021.1997196.
3
SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.SIRT1抑制通过增加慢性粒细胞白血病细胞中Ku70的乙酰化来损害非同源末端连接DNA损伤修复。
Oncotarget. 2016 Mar 22;7(12):13538-50. doi: 10.18632/oncotarget.6455.
4
Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway.联合 AT-101 和伊达比星对急性髓系白血病的合成致死作用：通过阻断 DNA 修复和激活内在凋亡途径。
Cancer Lett. 2019 Oct 1;461:31-43. doi: 10.1016/j.canlet.2019.07.003. Epub 2019 Jul 10.
5
The DNA double-strand break response is abnormal in myeloblasts from patients with therapy-related acute myeloid leukemia.治疗相关性急性髓系白血病患者的髓样母细胞中，DNA 双链断裂反应异常。
Leukemia. 2014 Jun;28(6):1242-51. doi: 10.1038/leu.2013.368. Epub 2013 Dec 5.
6
The role of the novel LincRNA uc002jit.1 in NF-kB-mediated DNA damage repair in acute myeloid leukemia cells.新型 LincRNA uc002jit.1 在 NF-kB 介导的急性髓系白血病细胞 DNA 损伤修复中的作用。
Exp Cell Res. 2020 Jun 15;391(2):111985. doi: 10.1016/j.yexcr.2020.111985. Epub 2020 Apr 4.
7
MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway.MAP4K1 通过调节 DNA 损伤/修复系统和 MAPK 通路，发挥肿瘤促进剂和 AML 药物介质的作用。
EBioMedicine. 2021 Jul;69:103441. doi: 10.1016/j.ebiom.2021.103441. Epub 2021 Jun 21.
8
RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.RUNX1 基因突变与细胞遗传学正常的急性髓系白血病不良预后相关，并导致淋巴样基因的上调。
Haematologica. 2012 Dec;97(12):1909-15. doi: 10.3324/haematol.2012.064667. Epub 2012 Jun 11.
9
High expression of FAMLF is associated with clinical response in patients with de novo acute myeloid leukemia.FAMLF的高表达与初发急性髓系白血病患者的临床反应相关。
Leuk Lymphoma. 2016 Nov;57(11):2727-30. doi: 10.3109/10428194.2016.1160087. Epub 2016 Apr 11.
10
Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.与DNA甲基化调节基因突变相关的急性髓系白血病的临床特征及预后
Haematologica. 2016 Sep;101(9):1074-81. doi: 10.3324/haematol.2016.143073. Epub 2016 May 31.

引用本文的文献

1
Mechanisms and signaling pathways of tyrosine kinase inhibitor resistance in chronic myeloid leukemia: A comprehensive review.慢性髓性白血病中酪氨酸激酶抑制剂耐药的机制和信号通路：综述
Leuk Res Rep. 2025 Aug 5;24:100533. doi: 10.1016/j.lrr.2025.100533. eCollection 2025.
2
Integrative multi-omic analysis of NLRP3 inflammasome dysregulation and subtyping for personalized treatment in acute myeloid leukemia.急性髓系白血病中NLRP3炎性小体失调的综合多组学分析及个性化治疗亚型分类
Discov Oncol. 2025 Jul 2;16(1):649. doi: 10.1007/s12672-025-02383-9.

本文引用的文献

1
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.DNA 聚合酶 θ 保护白血病细胞免受代谢诱导的 DNA 损伤。
Blood. 2023 May 11;141(19):2372-2389. doi: 10.1182/blood.2022018428.
2
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.急性髓系白血病药物反应与临床结局的综合分析。
Cancer Cell. 2022 Aug 8;40(8):850-864.e9. doi: 10.1016/j.ccell.2022.07.002. Epub 2022 Jul 21.
3
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.
一种用于理解急性髓系白血病异质性和预测药物反应的细胞层次结构框架。
Nat Med. 2022 Jun;28(6):1212-1223. doi: 10.1038/s41591-022-01819-x. Epub 2022 May 26.
4
Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia.克隆结构可预测急性髓系白血病的临床结果和药物敏感性。
Nat Commun. 2021 Dec 13;12(1):7244. doi: 10.1038/s41467-021-27472-5.
5
DNA Polymerase θ: A Cancer Drug Target with Reverse Transcriptase Activity.DNA 聚合酶 θ：一种具有逆转录酶活性的癌症药物靶点。
Genes (Basel). 2021 Jul 27;12(8):1146. doi: 10.3390/genes12081146.
6
A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors.一种一流的聚合酶θ抑制剂选择性靶向同源重组缺陷型肿瘤。
Nat Cancer. 2021 Jun;2(6):598-610. doi: 10.1038/s43018-021-00203-x. Epub 2021 Jun 17.
7
Acute myeloid leukemia: current progress and future directions.急性髓系白血病：当前进展与未来方向。
Blood Cancer J. 2021 Feb 22;11(2):41. doi: 10.1038/s41408-021-00425-3.
8
CDC42BPA/MRCKα: a kinase target for brain, ovarian and skin cancers.CDC42BPA/MRCKα：脑癌、卵巢癌和皮肤癌的激酶靶点。
Nat Rev Drug Discov. 2021 Mar;20(3):167. doi: 10.1038/d41573-021-00023-9.
9
AIM2 in health and disease: Inflammasome and beyond.AIM2 在健康与疾病中的作用：炎症小体及其他。
Immunol Rev. 2020 Sep;297(1):83-95. doi: 10.1111/imr.12903. Epub 2020 Jul 26.
10
Harnessing DNA Double-Strand Break Repair for Cancer Treatment.利用DNA双链断裂修复进行癌症治疗。
Front Oncol. 2019 Dec 10;9:1388. doi: 10.3389/fonc.2019.01388. eCollection 2019.